Diabetic Foot Ulcer Biologics Market Forecast 2025–2034
The Diabetic Foot Ulcer (DFU) biologics market focuses on advanced wound care products derived from natural biological sources such as human skin equivalents, placental tissue, collagen matrices, and growth factors designed to accelerate healing of chronic diabetic wounds. These biologics work by stimulating tissue regeneration, promoting angiogenesis, reducing inflammation, and supporting extracellular matrix formation processes often impaired in diabetic patients.